Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Stock Swap -- Ignore unavailable to you. Want to Upgrade?

To: Trader X who wrote (13534)	5/4/1998 12:42:00 AM
From: Jeffrey S. Mitchell	Read Replies (1) \| Respond to of 17305

Re: ENMD -- X-Man, good observation. Let me posit a guess why there has been no run-up. First off, from the S-1 I notice that ENMD is a DH Blair stock-- those fine folks who did the PLSIA pump and dump and were sanctioned by the SEC. In fact, it looks like DH Blair owns around 10% of ENMD. SEC filing: sec.gov Second, if we look at the chart in last November, prior to the publication in Nature of the spectacular results of the cancer inhibitor, the stock had tanked from 18 (at the IPO in 1/97) to 7, before rebounding with a vengeance to 15 by the end of November. This, to me, is quite fishy. Since it takes time for stuff to get published, my guess is Blair had prior knowledge of the article and made a killing. Chart: tscn.com Third, the publicity from the 3/31 press release probably made it difficult to tank the stock again. However, the fact they probably have tons more shares they need to unload means it is probably good to be at this level so they can gap up the price at the open and make a killing on what I think will be a buying frenzy. Lastly, given the way Blair operates, I predict an open of 15 and a high of at least to 18 and perhaps even 20 for a brief time -- with Blair selling all the way up -- followed by Blair shorting it back down. - Jeff